Delayed Hyper-Enhancement in Cardiac MRI Compared to Nuclear Perfusion Scintigraphy in Identification of Viable Myocardium in Patients of Myocardial Infarction – A Study

Bucha, Souza, Pant, and Joseph: Delayed Hyper-Enhancement in Cardiac MRI Compared to Nuclear Perfusion Scintigraphy in Identification of Viable Myocardium in Patients of Myocardial Infarction – A Study

Authors

INTRODUCTION

Myocardial infarction is the leading cause of death due to ischemic heart disease (IHD) in India and is also one of the most common causes of morbidity worldwide.1 Previously only people living in high income group countries were primarily thought to be affected by IHD, but recent studies and data confirm that IHD is the leading cause of death and disability in low and middle income countries which includes India, and the rates are increasing disproportionately when compared to those in high-income countries.2 In 2010-2013 itself, IHD accounted for 23 % of total and 32 % of all deaths in adult population in India.3 The “Global burden of disease study”, estimate of age standardized cardiovascular death rate of 272 per 100,000 population in India is higher than the global average of 235 per 100,000 population.4 Following myocardial infarction, prolonged ischemia and subsequent reperfusion can lead to myocardial inflammation and severe tissue damage by several immune mediated mechanisms.5 These cellular changes prime both the infarcted and non-infarcted cardiomyocytes for progressive ventricular dysfunction that eventually leads to a decline in function and heart failure.6,7 An early intervention at the time of reperfusion after the onset of acute MI has been shown to limit infarct size and restore blood flow in the ischemic tissue.5

“Myocardial Viability” is a concept which is based on the premise that in patients who have suffered myocardial infarction, even severely dysfunctional myocardium with areas of residual viable tissue may show functional recovery after revascularization.8 Differentiation of reversible and irreversible injury to myocardial tissue is of prime importance, as an appropriate course of action depends on whether the involvement is already trans-mural or whether some or all of the ‘at risk’ region contains focal areas of viable tissues in myocardium, which may be endangered in case of a future ischemic episode.9 Reversal of myocardial contractility may be of relevance in patients with reduced ventricular function but viable myocardium, as revascularization procedures may significantly improve long-term survival in them. Recent advances in the field of medicine and cardiology per se have led to the availability of a variety of non invasive methods to assess myocardial viability such as Thallium-201 SPECT / 99m-TC Sestamibi perfusion scan, low-dose Dobutamine stress echocardiography, Cardiac 18-FDG-PET scan, contrast enhanced cardiac MRI (CeMRI) for delayed hyper-enhancement.

MATERIALS AND METHODS

The present study was aimed to determine the effectiveness of contrast enhanced Cardiac MR (CeMRI) in detecting the viability of myocardial tissue as compared to Tc-99m Sestamibi perfusion scan in patients who have had myocardial infarction. A prospective observational clinical study was carried out comprising of a non-randomized sample of 42 patients (35 male and 07 females) of myocardial infarction (acute / chronic) in age group of 31 to 76 years with a median age 55.5 yrs, who presented to our tertiary care hospital and were awaiting coronary re-vascularization procedures. Necessary clearance from the institutional ethical committee was obtained and a written informed consent was taken from the patients at the time of their enrolment. The diagnosis of myocardial infarction was based on clinical signs and symptoms, typical ECG changes, cardiac enzyme markers (TROP-T and CK-MB) and ECHO findings. None of the patients had undergone coronary angioplasty or any other revascularization procedure before the study was performed. All the patients had no contraindication to MRI or to use of intravenous gadolinium contrast agents (i.e. contrast allergy / GFR < 30 ml/min). Patients having bundle branch block ECG patterns / unstable angina were excluded from study. The individuals enrolled for study were subjected to a complete medical history and clinical case record evaluation and the findings were noted down on a printed performa. Evaluation for myocardial viability was done by Tc-99m Sestamibi scan. The patients were then subjected to cardiac CeMR for demonstration of delayed hyper-enhancement.

Cardiac MRI protocol

Cardiac MR was performed on a 1.5 T magnet (Symphony, Siemens Medical Solutions, Erlangen, Germany) using a body coil. Cardiac sequences were gated to the patient’s cardiac cycle using ECG leads with image acquisition done at end of expiration. Localizers were acquired in three orthogonal planes followed by scout imaging in short axis, 2 chamber and 4 chamber views. Dark blood axial images were acquired along with TRUFI cine sequences in short axis, 2 chamber and 4 chamber views. For late gadolinium enhancement, multiple sequences with varying inversion time (TI) values were acquired and selected images with most appropriate TI were studied 15 minutes after i/v injection of gadolinium chelate contrast (0.1–0.2 mmol/kg) for delayed hyper enhancement. Inversion time set to null normal myocardium was in the range of 180 – 230 ms.

Image evaluation

The images produced were evaluated using vendor provided auto analysis software and PACS workstations and were analysed by a radiologist. The short-axis images were acquired and from these the heart was divided into three equal-sized regions (basal, middle, and apical) and sliced into 17 segments (based on the 17-segment model as proposed by Schiller et al.) Segment 17 was however not included for measurement of wall thickness due to high incidence of false positive results associated with its measurement. Various measurements were done as follows:

  1. Hyper-enhanced myocardium was identified 15 min after contrast administration as white regions with image intensities of >2 standard deviations (SD) above non enhanced myocardium which appeared dark after adequate nulling using double inversion recovery sequences.

  2. The wall thickness of this hyper-enhanced myocardium was then studied on the 17-segment model for each patient. The extent of hyper enhancement in each segment was graded as a percentage of the total wall thickness into different grades with Grade 0 - depicting no enhancement, Grade 1 - involving 1% –25% of wall thickness, Grade 2 - involving 26-50 %, Grade 3 - involving 51%–75% and Grade 4 - involving > 76% of wall thickness.

  3. Endo and epicardium were defined as the inner 50% (Grade 2) and outer 50% (Grade 3), respectively. Trans mural extent was described as Grade 4 of involvement. The myocardial tissue was divided into two groups based on the delayed hyper enhancement on MRI as “Viable myocardium” (involvement of ≤ 50 % wall thickness) and “Non-viable myocardium” (involvement of ≥ 50 % wall thickness).

Tc-99 Sestamibi perfusion protocol

Patients were subjected to a standard 12-lead ECG and SPECT myocardial perfusion imaging was performed subsequently. Patients were made to exercise on a treadmill (Bruce protocol) for 5 - 10 minutes up to a workload of 10.2 Mets. A total dose of 296 MBq (MCi) 99m TC MIBI was injected IV at peak stress and cardiac SPECT images were acquired thereafter. Rest study was conducted 3 hrs after completion of the stress study.

Image evaluation

The end point criterion was adequate level of exercise. Exercise tolerance was measured and ECG changes during the stress study were noted. Perfusion images were acquired in short axis, vertical and horizontal long axis for any defects and whether the defects reversed / persisted at rest suggestive of viable myocardial tissue / scar tissue. The images were analysed for presence or absence of perfusion defect and its extent. A nuclear medicine specialist reported the result.

RESULTS

Data was recorded on a pre-designed Performa and was managed on a Microsoft Excel sheet. Statistical Package for Social Sciences (IBM SPSS Statistics for Windows, Version 20.0. Armonk, NY: IBM Corp.) was used for Data analysis. The results of delayed hyper-enhancement on cardiac MRI were compared to the results of nuclear perfusion scan. Pearson Chi-Square test and Fisher’s Exact Test were used for statistical evaluation. In this study P value 0.0016 was considered statistically significant (Table 1 and 2).

Table 1

Original Table

MRI99Tc Sestamibi/Thallum 201Total
ViableNonviable
Viablecount191231
Percent61.3%38.7%100.0%
NonviableCount01111
Percent0.0%100.0%100.0%
TotalCount192342
Percent45.2%54.8%100.0%
Chi-Square testValuedfP valueAssociation is
Pearson chi-Square12.31110.0016Significant
Fisher’s Exact Test0.0003Significant

Out of the 42 patients studied, 14 (33.3 %) patients had acute MI, 27 (64.2%) patients had acute MI and 01 (2.3 %) patient had chronic MI.

(A) Cardiac CeMRI

  1. Territorial involvement of myocardial infarct on MRI - Out of 42 patients studied, 22 patients (52.38 %) had anterior wall MI, 13 patients (30.95 %) had inferior wall MI, 05 patients (11.90 %) presented with anterolateral wall MI and posterior wall MI was present in 02 patients (4.76 %).

  2. Segmental Involvement of infarcts - A total of 672 (16 segments x 42 patients) myocardial segments were studied for delayed hyper enhancement by cardiac MRI based on 17-segment model proposed by AHA (apical segment was not included). Delayed hyper enhancement was present in 98 segments constituting 14.58 % of the studied segments, with varying extent of the wall involvement.

    The mean signal intensity of the hyperenhanced myocardium on delayed MRI was 114.71 ± 21.162 and the mean signal intensity of the non enhanced myocardium was calculated as 26.52 ± 11.662. Probability that the difference in SI of enhanced and unenhanced myocardium was due to chance was 0.0004.

  3. Myocardial wall involvement by infarct on MRI - Normal myocardium with no evidence of delayed hyper enhancement was observed in 11 patients (26.19 %). 09 (21.42 %) patients had infarcts involving 0-25 % wall thickness, 11 (26.19%) patients were found to have 26-50 % wall thickness involvement by infarcts and in 04 (9.52 %) patients infarcts involving 51-75 % wall thickness were found. Transmural infarcts involving > 75 % wall thickness were observed in 07 (16.66 %) patients (Figure 1).

Figure 1

Extent of myocardial enhancement observed on CeMRI.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-15_g001.jpg

(A) Tc-99 Sestamibi Nuclear perfusion:

Nuclear perfusion scintigraphy studies showed viable myocardium in 19 patients (45.24 %) [normal study was observed in 11 patients (57.89 %) and reversible perfusion defects were seen in 08 patients (42.10 %)]. Fixed perfusion defects suggestive of non-viable myocardial myocardial tissue were seen in 23 patients (54.76 %).

05 patients (50 %) out of 10 patients with normal nuclear perfusion studies showed normal MR studies with no delayed enhancement while 05 (50 %) patients had delayed hyper enhancement on MRI which was sub-endocardial in extent. 03 patients (33.33 %) out of 09 patients with reversible perfusion defect on nuclear perfusion scans had delayed hyper-enhancement on MRI which was sub-endocardial in location and 06 patients (66.66 %) were found to have normal MRI.

16 patients (69.56 %) out of 23 patients who had fixed perfusion defects on nuclear perfusion scans had partial thickness infarcts on MRI [12 patients (75 %) had < 50 % wall thickness involvement and 04 patients (25 %) had 50-75 % wall thickness involvement]. Trans-mural infarcts (>75 %) with scarring on MRI were seen in 07 patients (30.43 %) with fixed perfusion defects on nuclear scan (Figure 2). The association of detecting myocardial viability on MRI and nuclear perfusion scans was statistically significant (Figure 3).

Figure 2

Distribution of viable vs non-viable myocardium on nuclear perfusion scan.

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-15_g002.jpg
Figure 3

Scatter diagram showing the correlation between CeMRI & nuclear perfusion scan in detecting myocardial viability

https://s3-us-west-2.amazonaws.com/jourdata/jcdr/JCardVascDisRes-9-15_g000.jpg

Statistical performance of MRI

The sensitivity of delayed hyper enhancement MRI for detection of viable myocardium in the study group was 100 % and the specificity was 47.83 %. The positive predictive value of the modality in detecting viability was 61.29 % with a diagnostic accuracy of 71.43 %.

DISCUSSION

The most common implicating event in causation of myocardial infarction is coronary artery occlusion secondary to embolization by an unstable coronary plaque. Hypoxia caused by such an occlusion causes initial cellular changes in the myocardial tissues in the territory supplied by the occluded vessel, which causes a progressive decline in the ventricular function and sometimes heart failure, if a large area is involved. Without critical blood supply, the inflammatory mediators such as cytokines are activated in the infarcted region that leads to the initiation of cellular processes of necrosis, apoptosis and autophagy, which further leads to loss of functional cardiomyocytes.10,11 These processes occur simultaneously in the hypoxic tissue as the affected cells struggle to survive or die. These inflammatory pathways are critically involved both in repair as well as remodeling of the infarcted myocardium. β-adrenergic receptors (AR) serve as critical regulators of cardiac function at the level of the myocardium and in circulation.12 Post myocardial infarction, β1 adrenergic signaling in myocardial cells is seen to be associated with cardiac hypertrophy, ventricular remodeling and apoptosis. A study by Shashi Bhushan et. al. (2012)13 demonstrated that selective β2-adrenoreceptor stimulation attenuates myocardial cell death and preserves cardiac function after ischemia–reperfusion injury.13

Altering the initial cell responses to ischemia may enhance cardiomyocyte survival and ultimately preserve myocardial function following MI.11 Early and effective restoration of the vital blood supply to the at risk myocardium is the most effective current clinical therapy aimed at improving blood flow to the non perfused myocardial cells.14 Therapeutic approaches targeting specific components of the inflammatory response hold promise for patients with myocardial infarction Cardio-protective effect of interventions for patients experiencing MI is very essential to restore cardiac function.

Dysfunctional myocardium with focal areas of viable tissues has the potential for contractile recovery after reperfusion.15 This distinction between viable myocardial tissue and non viable necrotic tissue is a pre-operative predictor of the benefit of any revascularization procedure. Location of viable myocardium, especially in the sub-epicardial location, may have an important influence on long-term ventricular function.16 The principle of determination of myocardial viability on CeMRI is based on the observation that infarcted area (necrosed tissue), enhances avidly, 10-15 minutes after intravenous contrast administration.17 This delayed hyper enhancement has been shown to correlate precisely with the actual extent of infarct as observed in various animal and human studies.17,18 Viability imaging thus reliably helps to identify areas of hibernation and viable or non-viable myocardium.

A combination of delayed hyper-enhancement on CeMRI and assessment of segmental wall motion by cine-MRI yields better information about myocardial contractile reserve. In general, presence of mild degrees of hyper-enhancement (involving <25% of the segment) with normal wall motion suggests that contractile function of that segment will recover, whereas the presence of higher degrees of hyper-enhancement (>75% of the segment) strongly suggests that no effective recovery of contractile function will occur even after revascularization.18 The outcome after revascularization however, is less clear in dysfunctional segments showing intermediate degrees of hyper enhancement (>25% and <75%). In such cases, trans-mural infarcts were found to be associated with no recovery of contractile function.19,20

Sandstede et al. (2000) reported that delayed hyper enhancement of dysfunctional myocardium predicts lack of mechanical improvement or non viability, whereas the lack of hyper enhancement predicts improvement of regional contractility for viability after revascularization.20,21

Gerber et al. (2001) reported that segments with trans-mural hyper enhancement showed no significant inotropic reserve when assessed with low-dose Dobutamine tagged MRI, and non trans-mural hyper enhancement was associated with contractile reserve, consistent with residual viability.21

The present study conducted at our hospital also showed that cardiac MRI using delayed hyper enhancement technique and nuclear perfusion studies detected trans-mural myocardial infarcts at similar rates. However, cardiac MRI was able to detect sub endocardial infarcts (< 50 % wall thickness) in some cases (33%), which were totally missed in nuclear perfusion imaging that had demonstrated a normal study. Thus MRI was found to be more sensitive than nuclear perfusion scans for detecting sub endocardial infarcts. It was also found that the sensitivity of delayed hyper enhancement on MRI for detection of viable myocardium was 100 % with a specificity of 47.83 %. The positive predictive value of the modality was 61.29 % with a diagnostic accuracy of 71.43 %.

The general idea that SPECT misses small infarcts has been previously reported by,22,21 which also demonstrated that SPECT was poor at picking up small sub endocardial infarcts as compared to the MR imaging.22,23

In a study by Anja et al. a comparing contrast enhanced cardiac MRI with SPECT also found that SPECT not only misses some infarcts, but also a large proportion of patients in whom infarct is missed, the SPECT scan is completely normal.24 In a large proportion of such patients, delayed-enhancement cardiac MRI was able to detect sub-endocardial infarcts in 92%, whereas SPECT detected only 28%. Due to low spatial resolution and degradation of image quality associated with SPECT, the study is limited, especially in the detection of small and sub endocardial infarcts.25,26

Thus to conclude, necrotic myocardium and scar resulting from myocardial infarction, may be distinguished from normal myocardium by magnetic resonance imaging (MRI), an operator independent technique, which is quite safe for patients.27,28 Contrast enhanced MRI (CeMRI) seems to be clinically useful and reproducible in scar detection.29 Though nuclear perfusion study is the gold standard for demonstrating myocardial viability, CeMRI is more sensitive in demonstrating sub-endocardial infarcts which is possibly because of higher contrast and spatial resolution of the MRI as compared to nuclear imaging. The excellent tissue characterization function enables MRI to detect viable myocardium accurately. Contrast enhanced MRI provides information on tissue perfusion, cellular integrity and membrane function and has the potential to replace or complement other commonly used techniques in the diagnosis of viable and irreversibly damaged myocardium.

CONFLICT OF INTERESTS

The authors have none to declare.

CONCLUSION

Contrast enhanced MRI has high sensitivity in the detection of viable and irreversibly damaged myocardium and has the potential to replace or complement nuclear perfusion scans in detecting myocardial viability in patients of myocardial infarction.

ACKNOWLEDGEMENT

We would like to acknowledge everybody who contributed in the completion of the study including the technical staff. We also hereby transfer, assign, or otherwise convey all copyright ownership, including any and all rights incidental thereto, exclusively to the journal, in the event that such work is published by the journal.

ABBREVIATION USED

IHD

Ischemic heart disease

MI

Myocardial infarction

CeMRI

Contrast enhanced magnetic resonance imaging

SPECT

Single photon emission computed tomography.

REFERENCES

1. 

Reddy KS, Shah B, Varghese C, Ramadoss A , authors. Responding to the threat of chronic diseases in India. Lancet. 2005;366:1744–49

2. 

Xavier D, Pais P, Devereaux PJ, Xie C, Prabhakaran D, Reddy KS , authors. et al. CREATE registry investigators. Treatment and outcomes of acute coronary syndromes in India (CREATE): a prospective analysis of registry data. Lancet. 2008;371:1435–42

3. 

Rajeev Gupta, Indu Mohan, Jagat Narula , authors. Trends in Coronary Heart Disease Epidemiology in India. Annals of Global Health. 2016;82(2):307–15

4. 

Prabhakaran D, Jeemon P, Roy A , authors. Cardiovascular disease in India: Current epidemiology and future directions. Circulation. 2016;133(16):1605–20

5. 

Jones SP, Hoffmeyer MR, Sharp BR, Ho YS, Lefer DJ , authors. Role of intracellular antioxidant enzymes after in vivo myocardial ischemia and reperfusion. Am J Physiol Heart Circ Physiol. 2003;284(1):H277–82. [PubMed: 12485820].

6. 

Jugdutt BI , author. Ischemia/Infarction. Heart Fail Clin. 2012;8:43–51

7. 

Frangogiannis NG, Smith CW, Entman ML , authors. The inflammatory response in myocardial infarction. Cardiovasc Res. 2002;53(1):31–47

8. 

Pagano D, Fath-Ordoubadi F, Beatt KJ, Townend JN, Bonser RS, Camici PG , authors. Effects of coronary revascularization on myocardial blood flow and coronary vasodilator reserve in hibernating myocardium. Heart. 2001;85(2):208–12

9. 

Claussen JV, Rochitte CE, Wu KC, Kamel IR, Foo TK, Lima JA , authors. et al. Delayed Enhancement MR Imaging: Utility in Myocardial Assessment. Radiographic. 2006;26(3):795–810

10. 

Kanamori H, Takemura G, Goto K, Maruyama R, Tsujimoto A , authors. et al. The role of autophagy emerging in post-infarction cardiac remodeling. Cardiovasc Res. 2011;91(2):330–9

11. 

Kung G, Konstantinidis K, Kitsis RN , authors. Programmed necrosis, not apoptosis, in the heart. Circ Res. 2011;108(8):1017–36

12. 

Laurel AG, Anna MG, Christopher J , authors. et al. Leukocyte-Expressed β2-Adrenergic Receptors are Essential for Survival Following Acute Myocardial Injury. Circulation. 2016;34(2):153–67

13. 

Shashi Bhushan, Kazuhisa Kondo, Benjamin LP, Maxim Z, Adrienne LK , authors. et al. Selective β2-Adrenoreceptor Stimulation Attenuates Myocardial Cell Death and Preserves Cardiac Function After Ischemia – Reperfusion Injury. Arterioscler Thromb Vasc Biol. 2012;32(8):1865–74

14. 

Keeley EC, Hillis LD , authors. Primary PCI for myocardial infarction with ST- segment elevation. N Engl J Med. 2007;356(1):47–54

15. 

Rahimatoola SH , author. A perspective on the three large multicenter randomized clinical trials of coronary bypass surgery for chronic stable angina. Circulation. 1985;72(6):123–35

16. 

Kaul S , author. There may be more to myocardial viability than meets the eye. Circulation. 1995;92(10):2790–3

17. 

Kim RJ, Lima JA, Chen EL , authors. et al. Fast 23Na magnetic resonance imaging of acute reperfused myocardial infarction. Potential to assess myocardial viability. Circulation. 1997;95(7):1877–85

18. 

Fieno DS, Kim RJ, Chen EL , authors. et al. Contrast-enhanced magnetic resonance imaging of myocardium at risk: distinction between reversible and irreversible injury throughout infarct healing. J Am Coll Cardiol. 2000;36(6):1985–91

19. 

Shan K, Constantine G, Sivananthan M, Flamm SD , authors. Role of cardiac magnetic resonance imaging in the assessment of myocardial viability. Circulation. 2004;109(11):1328–34

20. 

Sandstede JW, Lipke C, Beer M , authors. et al. Analysis of first-pass and delayed contrast-enhancement patterns of dysfunctional myocardium on MR imaging: use in the prediction of myocardial viability. AJR. 2000;174(6):1737–40

21. 

Gerber BL, Rochitte CE, Bluemke DA , authors. et al. Relation between Gd-DTPA contrast enhancement and regional inotropic response in the periphery and center of myocardial infarction. Circulation. 2001;104(9):998–1004

22. 

Chida K, Sugiura M, Ohkawa S , authors. et al. A clinico-pathologic correlation study of thallium-201 myocardial scintigraphy in diagnosis of myocardial infarction. Jpn Heart J. 1987;28(3):307–21

23. 

Kontos MC, Kurdziel KA, Ornato JP, Schmidt KL, Jesse RL, Tatum JL , authors. A non-ischemic electrocardiogram does not always predict a small myocardial infarction: results with acute myocardial perfusion imaging. Am Heart J. 2001;141(3):360–6

24. 

Lin LC, Ho YL, Wu CC , authors. et al. Comparison of simultaneous dobutamine echocardiography and thallium-201 stress-reinjection single-photon emission computed tomography in predicting improvement of chronic myocardial dysfunction after revascularization. Am J Cardiol. 2000;86(3):293–8

25. 

Miller TD, Christian TF, Hopfenspirger MR, Hodge DO, Gersh BJ, Gibbons RJ , authors. Infarct size after acute myocardial infarction measured by quantitative tomographic 99mTc Sestamibi imaging predicts subsequent mortality. Circulation. 1995;92(3):334–41

26. 

Gibbons RJ, Miller TD, Christian TF , authors. Infarct size measured by single photon emission computed tomographic imaging with (99m) Tc-Sestamib: a measure of the efficacy of therapy in acute myocardial infarction. Circulation. 2000;101(1):101–8

27. 

Kim RJ, Wu E, Rafael A, Chen EL, Parker MA, Simonetti O , authors. et al. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction. N Engl J Med. 2000;343(20):1488–90

28. 

Wu E, Judd RM, Vargas JD, Klocke FJ, Bonow RO, Kim RJ , authors. Visualization of presence, location, and trans-mural extent of healed Q-wave and non-Q-wave myocardial infarction. Lancet. 2001;357(2949):21–8

29. 

Mahrholdt H, Wagner A, Holly TA, Elliott MD, Bonow RO, Kim RJ , authors. et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation. 2002;106(18):2322–7